ALLMedicine™ Depression Center

May 7th, 2021 - Despite a strong link between suicide risk and depression, a recent literature review found that many effectiveness studies for online depression interventions exclude individuals at risk of suicide. This study scrutinizes how different suicide ri...

May 7th, 2021 - Continuation and maintenance ECT (c-/m-ECT) are effective in the prevention of relapse and recurrence of both affective and psychotic disorders. However, data are scarce concerning the trajectories of severe mental disorders after the end of c-/m-...

May 7th, 2021 - Components of rumination, including brooding and reflection, as well as devaluating prospective positivity, may help maintain depressive symptoms. We examined these components together for the first time using network analysis. We examined the rob...

May 7th, 2021 - In contrast to the dose-occupancy relationship in the treatment of schizophrenia, the minimal effective level of dopamine receptor 2 (D2R) blockade for antipsychotics in the treatment of bipolar depression is unknown. Lower doses aimed at relievin...

May 7th, 2021 - Depression is a heterogeneous condition, with multiple possible symptom-profiles leading to the same diagnosis. Descriptive depression subtypes based on observation and theory have so far proven to have limited clinical utility. To identify depres...

Mar 23rd, 2021 - Healthcare workers have been facing the COVID-19 pandemic, with numerous critical patients and deaths, and high workloads. Quality of care is related to the mental status of healthcare workers. This PRISMA systematic review and meta-analysis, on P...

Feb 6th, 2021 - This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clini...

Jan 6th, 2021 - Physician burnout is a serious problem with serious consequences; it is associated with increased risk of depression, impaired quality of life, substance abuse, and suicide. Not surprisingly, in a recent survey of 7,500 physicians, 64% (half of wh...

Dec 31st, 2020 - Is augmentation with a second antidepressant or an atypical antipsychotic effective for treatment-resistant depression in adults?

Dec 8th, 2020 - Chronic nightmares are very common in psychiatric disorders, affecting up to 70% of patients with personality or post-traumatic stress disorders. In other psychiatric disorders, the relationships with nightmares are poorly known. This review aimed...

May 7th, 2021 - Despite a strong link between suicide risk and depression, a recent literature review found that many effectiveness studies for online depression interventions exclude individuals at risk of suicide. This study scrutinizes how different suicide ri...

May 7th, 2021 - Continuation and maintenance ECT (c-/m-ECT) are effective in the prevention of relapse and recurrence of both affective and psychotic disorders. However, data are scarce concerning the trajectories of severe mental disorders after the end of c-/m-...

May 7th, 2021 - Components of rumination, including brooding and reflection, as well as devaluating prospective positivity, may help maintain depressive symptoms. We examined these components together for the first time using network analysis. We examined the rob...

May 7th, 2021 - In contrast to the dose-occupancy relationship in the treatment of schizophrenia, the minimal effective level of dopamine receptor 2 (D2R) blockade for antipsychotics in the treatment of bipolar depression is unknown. Lower doses aimed at relievin...

May 7th, 2021 - Depression is a heterogeneous condition, with multiple possible symptom-profiles leading to the same diagnosis. Descriptive depression subtypes based on observation and theory have so far proven to have limited clinical utility. To identify depres...

May 3rd, 2021 - Critical care nurses (CCNs) across the country reported high levels of stress, depression, and anxiety even before the onset of the COVID-19 pandemic, and these factors correlated with an increase in self-reported medical errors, a cross-sectional...

May 2nd, 2021 - The US Food and Drug Administration (FDA) has approved a higher-dose naloxone hydrochloride nasal spray (Kloxxado) for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depres...

Apr 29th, 2021 - Testing for anxiety or depression should be offered periodically — perhaps for months to years — to patients with implantable cardioverter defibrillators (ICD), not just in the early period after implantation, suggests a prospective cohort study. ...

Apr 29th, 2021 - Motor problems in children may be a harbinger of serious mental illness, new research suggests. Investigators found that motor abnormalities were twice as common among those who develop psychosis or depression compared to their counterparts in the...

Apr 27th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 and its resulting lockdowns are linked to posttraumatic stress disorder (PTSD) symptoms and other adverse outcomes among patients with ea...